NuGen Medical Devices Inc. (TSXV:NGMD)
Canada flag Canada · Delayed Price · Currency is CAD
0.0250
+0.0050 (25.00%)
At close: May 8, 2026

NuGen Medical Devices Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.146.950.460.131.75
Cash & Short-Term Investments
3.146.950.460.131.75
Cash Growth
-54.84%1395.51%253.33%-92.49%556.92%
Accounts Receivable
0.050.10.020.010.01
Other Receivables
0.060.230.330.240.3
Total Trade Receivables
0.120.330.360.240.31
Inventory
0.50.320.210.080.01
Other Current Assets
0.240.210.30.120.07
Total Current Assets
3.997.81.330.572.15
Net Property, Plant & Equipment
0.30.010.030.160.02
Other Intangible Assets
-3.363.894.455.02
Goodwill
-1.731.691.671.67
Total Assets
4.2912.896.956.858.84
Accounts Payable
0.580.681.071.490.91
Current Portion of Long-Term Debt
2.980.572.140.08-
Current Portion of Leases
--0.030.12-
Unearned Revenue
0.070.080.050.04-
Other Current Liabilities
----0.33
Total Current Liabilities
3.631.343.291.731.23
Long-Term Debt
14.417.235.727.165.61
Long-Term Leases
---0.04-
Other Long-Term Liabilities
---0.180.35
Total Long-Term Liabilities
14.417.235.727.385.95
Total Liabilities
18.0318.579.019.117.19
Common Stock
23.323.2221.3615.0714.19
Additional Paid-in Capital
4.055.445.923.53.52
Accumulated Other Comprehensive Income
-0.260.04-0.04-0.23-0.25
Retained Earnings
-40.83-34.37-29.3-20.61-
Shareholders' Equity
-13.74-5.67-2.06-2.261.66
Total Liabilities & Equity
4.2912.896.956.858.84
Total Debt
17.3817.87.887.415.61
Net Cash (Debt)
-14.24-10.86-7.42-7.28-3.86
Net Cash Per Share
-0.06-0.05-0.04-0.08-0.06
Book Value
-13.74-5.67-2.06-2.261.66
Book Value Per Share
-0.06-0.03-0.01-0.030.02
Tangible Book Value
-13.74-10.75-7.65-8.38-5.02
Tangible Book Value Per Share
-0.06-0.05-0.05-0.09-0.07
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.